510(k) for Interpore's AGF (autologous growth factor) collection system:
This article was originally published in Clinica
The US FDA has cleared Interpore Cross International's UltraConcentrator permeability haemodialyser and automated processor. The products are components of a system used during bone grafting procedures for collecting autologous growth factors, a platelet-rich plasma derivative providing osteoinductive growth factors from the patient's blood. The automated processor provides a pneumatic, semi-automated method of driving a platelet-rich blood component called the buffy coat through the UltraConcentrator which, in turn, removes the water and concentrates the platelets and fibrin.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.